Cross-talk among writers, readers, and erasers of m6A regulates cancer growth and progression S Panneerdoss, VK Eedunuri, P Yadav, S Timilsina, S Rajamanickam, ... Science advances 4 (10), eaar8263, 2018 | 287 | 2018 |
MiR-584-5p potentiates vincristine and radiation response by inducing spindle defects and DNA damage in medulloblastoma N Abdelfattah, S Rajamanickam, S Panneerdoss, S Timilsina, P Yadav, ... Nature communications 9 (1), 4541, 2018 | 58 | 2018 |
Cross-talk between miR-471-5p and autophagy component proteins regulates LC3-associated phagocytosis (LAP) of apoptotic germ cells S Panneerdoss, S Viswanadhapalli, N Abdelfattah, BC Onyeagucha, ... Nature communications 8 (1), 598, 2017 | 56 | 2017 |
Inhibition of FoxM1-mediated DNA repair by imipramine blue suppresses breast cancer growth and metastasis S Rajamanickam, S Panneerdoss, A Gorthi, S Timilsina, B Onyeagucha, ... Clinical Cancer Research 22 (14), 3524-3536, 2016 | 54 | 2016 |
M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression P Yadav, P Subbarayalu, D Medina, S Nirzhor, S Timilsina, ... Cancer research 82 (10), 1872-1889, 2022 | 48 | 2022 |
Downregulation of KCNMB4 expression and changes in BK channel subtype in hippocampal granule neurons following seizure activity LE Whitmire, L Ling, V Bugay, CM Carver, S Timilsina, HH Chuang, ... PLoS One 12 (11), e0188064, 2017 | 27 | 2017 |
Abstract P2-03-04: down-regulation of Bcl2-related ovarian killer (BOK) by miR-296-5p protects breast cancer cells from paclitaxel-induced apoptosis BC Onyeagucha, S Rajamanickam, P Subbarayalu, B Bansal, H Bansal, ... Cancer Research 76 (4_Supplement), P2-03-04-P2-03-04, 2016 | 26 | 2016 |
Topological Characterization of Human and Mouse m5C Epitranscriptome Revealed by Bisulfite Sequencing Z Wei, S Panneerdoss, S Timilsina, J Zhu, TA Mohammad, ZL Lu, ... International Journal of Genomics 2018 (1), 1351964, 2018 | 24 | 2018 |
Novel post-transcriptional and post-translational regulation of pro-apoptotic protein BOK and anti-apoptotic protein Mcl-1 determine the fate of breast cancer cells to survive … B Onyeagucha, P Subbarayalu, N Abdelfattah, S Rajamanickam, ... Oncotarget 8 (49), 85984, 2017 | 21 | 2017 |
The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events S Timilsina, S Rajamanickam, A Rao, P Subbarayalu, S Nirzhor, ... Cancer letters 540, 215717, 2022 | 14 | 2022 |
Cross-talk among writers, readers, and erasers of m6A regulates cancer growth and progression. Sci Adv. 2018; 4: eaar8263 S Panneerdoss, VK Eedunuri, P Yadav, S Timilsina, S Rajamanickam, ... | 10 | |
Epigenetic and transcriptional regulation of innate immunity in cancer C Chen, N Man, F Liu, GM Martin, H Itonaga, J Sun, SD Nimer Cancer research 82 (11), 2047-2056, 2022 | 9 | 2022 |
Targeting aberrant replication and DNA repair events for treating breast cancers S Rajamanickam, JH Park, P Subbarayalu, S Timilsina, K Bates, P Yadav, ... Communications Biology 5 (1), 493, 2022 | 3 | 2022 |
Abstract P4-05-09: Matrin 3: a novel micro-tubule associated RNA binding protein that acts as a potent tumor suppressor P Subbarayalu, S Rajamanickam, S Viswanadhapalli, ... Cancer Research 75 (9_Supplement), P4-05-09-P4-05-09, 2015 | 3 | 2015 |
The RNA Demethylase ALKBH5 Maintains Endoplasmic Reticulum Homeostasis by Regulating UPR, Autophagy, and Mitochondrial Function P Subbarayalu, P Yadav, S Timilsina, D Medina, K Baxi, R Hromas, ... Cells 12 (9), 1283, 2023 | 1 | 2023 |
Abstract PS19-14: Matrin3 inhibits breast cancer growth by suppressing microtubule nucleation protein MZT2B P Subbarayalu, S Rajamanickam, S Viswanadhapalli, F Li, V Eedunuri, ... Cancer Research 81 (4_Supplement), PS19-14-PS19-14, 2021 | 1 | 2021 |
Imipramine, an FDA approved anti-depressant, suppresses triple negative breast cancer growth and progression through inhibition of FOXM1 and DNA repair pathways S Timilsina, S Rajamanickam, I Jatoi, Y Chen, R Vadlamudi, V Kaklamani, ... Cancer Research 80 (16_Supplement), 2975-2975, 2020 | 1 | 2020 |
Abstract P3-03-10: Targeting Wnt/β-catenin pathway by antidepressant imipramine for triple negative breast cancer treatment S Rajamanickam, S Timilsina, I Jatoi, V Kaklamani, RK Vadlamudi, ... Cancer Research 80 (4_Supplement), P3-03-10-P3-03-10, 2020 | 1 | 2020 |
Abstract A45: tumor suppressor miR-584-5p regulates MYC and sensitizes MYC-amplified medulloblastoma to vincristine and ionizing radiation N Abdelfattah, S Rajamanickam, S Timilsina, P Subbarayalu, ... Cancer Research 78 (19_Supplement), A45-A45, 2018 | 1 | 2018 |
Abstract P6-06-04: Targeting replication stress in triple negative breast cancer treatment regimen: An emerging approach S Rajamanickam, JH Park, K Bates, S Timilsina, VK Eedunuri, ... Cancer Research 78 (4_Supplement), P6-06-04-P6-06-04, 2018 | 1 | 2018 |